| Secondary |
| Product Used For Unknown Indication |
51.5% |
| Drug Use For Unknown Indication |
14.8% |
| Ill-defined Disorder |
7.8% |
| Constipation |
4.4% |
| Infection |
2.7% |
| Pyrexia |
2.7% |
| Colitis Ulcerative |
2.3% |
| Otitis Media Acute |
2.3% |
| Insomnia |
1.9% |
| Decreased Appetite |
1.7% |
| Enteritis |
1.1% |
| Malnutrition |
1.1% |
| Osteoporosis |
1.1% |
| Influenza |
0.9% |
| Diuretic Therapy |
0.8% |
| Hypersensitivity |
0.8% |
| Diarrhoea |
0.6% |
| Enterocolitis |
0.6% |
| Hypertension |
0.6% |
| Nasopharyngitis |
0.6% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
14.6% |
| Abnormal Behaviour |
10.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
10.4% |
| Stevens-johnson Syndrome |
8.3% |
| Hepatitis Acute |
6.3% |
| Pyrexia |
6.3% |
| Vasculitis |
6.3% |
| Lymphocyte Stimulation Test Positive |
4.2% |
| Sensory Disturbance |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Vomiting |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Drug Eruption |
2.1% |
| Hallucination, Auditory |
2.1% |
| Hepatic Function Abnormal |
2.1% |
| Hepatitis |
2.1% |
| Hypoaesthesia |
2.1% |
| Intestinal Ischaemia |
2.1% |
| Intestinal Obstruction |
2.1% |
| Muscle Spasms |
2.1% |
|
| Concomitant |
| Prophylaxis |
15.0% |
| Drug Use For Unknown Indication |
9.3% |
| Hypertension |
9.0% |
| Product Used For Unknown Indication |
8.4% |
| Colitis Ulcerative |
7.2% |
| Insomnia |
5.4% |
| Crohn's Disease |
5.2% |
| Rheumatoid Arthritis |
5.0% |
| Constipation |
5.0% |
| Diarrhoea |
4.1% |
| Gastritis |
3.8% |
| Graft Versus Host Disease |
3.3% |
| Asthma |
3.2% |
| Osteoporosis |
3.0% |
| Hiv Infection |
2.7% |
| Influenza |
2.3% |
| Gastroenteritis |
2.0% |
| Multiple Myeloma |
2.0% |
| Premedication |
2.0% |
| Renal Cell Carcinoma |
2.0% |
|
| Vomiting |
10.5% |
| Platelet Count Decreased |
9.3% |
| Pyrexia |
8.1% |
| Rash |
6.9% |
| Interstitial Lung Disease |
6.2% |
| Hepatic Function Abnormal |
5.9% |
| White Blood Cell Count Decreased |
5.2% |
| Colitis Ulcerative |
4.8% |
| Renal Impairment |
4.8% |
| Liver Disorder |
4.5% |
| Sepsis |
4.3% |
| Pneumonia |
4.0% |
| Renal Failure Acute |
3.6% |
| Respiratory Failure |
3.6% |
| Drug Exposure During Pregnancy |
3.3% |
| Somnolence |
3.3% |
| Pneumonia Aspiration |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Renal Disorder |
2.9% |
| Rhabdomyolysis |
2.9% |
|
